Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion
![](https://bluesight.com/wp-content/uploads/2022/06/Diversion-Trends-Report_2022_Cover-1-150x150.png)
Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion
Kit Check, the industry leader in Medication Intelligence™ solutions for hospitals, today announced the findings…
![](https://bluesight.com/wp-content/uploads/2021/02/2020-category-leader-drug-diversion-monitoring-150x150.jpg)
Bluesight for Controlled Substances Named Category Leader in Best in KLAS 2020 Report
Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We …
Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report
KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering …
Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring
Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …
![](https://bluesight.com/wp-content/uploads/2021/02/KLAS_barchart-150x150.jpg)
Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report
Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. …
1 of 1